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Liver cystic metastases are rare and mostly come from colon, pancreas, ovary, kidney, neuro-
endocrine, and prostate cancer. Nasopharyngeal carcinoma (NPC) with liver cystic metastasis
has only been reported once. Here, we report a 52-year-old man with liver cystic metastasis
from locally cured NPC. The patient received concurrent chemoradiotherapy for NPC 4 years
ago and presented with a 6-month history of upper abdominal fullness and pain. No evidence
of local recurrence of NPC was found at his regular follow-up examinations after concurrent
chemoradiotherapy. Abdominal magnetic resonance imaging showed a large, well-defined,
lobulated cystic lesion with poor contrast enhancement occupying both lobes of the liver. He-
patic cystic metastasis was suspected. Ultrasound-guided liver tumor biopsy was performed.
Histological examinations disclosed a pattern of poorly differentiated squamous cell carcinoma
with focal sarcomatoid differentiation based on the P40 immunohistochemical stain. In situ hy-
bridization for EpsteineBarr virus early RNAs confirmed the diagnosis of metastatic NPC. It is
difficult to make a diagnosis in liver cystic neoplasms, especially from a rarely reported origin.
In our case, we used clinical history and EpsteineBarr virus early RNAs as a specific marker to
make an accurate diagnosis.
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Nasopharyngeal carcinoma (NPC) is an epithelial cancer
related to EpsteineBarr virus (EBV). NPC is endemic to
certain well-defined populations. The highest incidence of
NPC is found in a Cantonese region of Southern China. In
Taiwan, there were 1579 new cases of NPC in 2007, and this
condition ranked as the 10th most common cancer affecting
the male population, with an annual incidence rate of 10.05
per 100,000 men [1]. NPC shows a rate as high as one-third
for local or locoregional recurrence or metastasis. In
various reports, the incidence of distant metastases from
NPC ranges from 17% to 54%. Bone, lung, liver, and distant
lymph nodes are the most common sites of distant metas-
tases. Most liver metastases from NPC are solid, and cystic
metastases are rarely reported [2].
Liver cystic lesions represent a heterogeneous group of
disorders. Most liver cystic lesions tend to have a benign
course. However, liver cystic neoplasms are rare and may
vary from benign to overtly malignant [3]. The most
commonly reported liver cystic neoplasm is cystadenoma.
Other liver cystic neoplasms including primary neoplasms
(cystadenocarcinoma and squamous cell carcinoma) or
secondary from metastases (ovary, pancreas, and colon)
are rarely reported. The origin of these liver cystic neo-
plasms may present a diagnostic challenge in daily practice.
Here, we report a case of liver cystic metastatic neoplasms
from NPC without evidence of local recurrence. EBV early
RNAs (EBERs) are a valuable tool for accurate diagnosis of
liver metastatic cystic neoplasms from NPC.Figure 1 A large, well-defined, lobulated mixed cystic and solid l
T1-weighted imaging (A), hyperintensity on T2-weighted imaging (
the lesion revealed poor contrast enhancement (D).Case report
A 52-year-old man presented with abdominal fullness and
pain and body weight loss of 5 kg in the past 6 months. He
had a history of nonkeratinizing undifferentiated NPC,
cT2aN2M0, Stage III and underwent concurrent chemo-
radiotherapy 4 years ago. There was no evidence of local
recurrence in his recent regular follow-up examinations. He
also had history of gastric ulcer bleeding and received
subtotal gastrectomy 25 years ago. He had no known spe-
cific family history. He drank alcohol occasionally and was
also a smoker for 25 years. Physical examinations revealed
hepatomegaly (liver span of 15 cm in the right subclavian
line and 9 cm in the sternum midline) with local tenderness
over the epigastric region. Laboratory data showed anemia
with hemoglobin 9.8 mg/dL (normal range: 13e17 mg/dL);
normal serum total bilirubin 0.4 g/L (normal range:
0.5e1.5 g/L); normal aspartate aminotransferase 27 U/L
(normal range: < 37 U/L); normal alanine aminotransferase
15 U/L (normal range: < 40 U/L); abnormal serum alkaline
phosphatase 489 U/L (normal range: 40e129 U/L);
abnormal r-glutamyl transpeptidase 302 U/L (normal range:
5e36 U/L); normal serum a-fetoprotein 2.05 ng/mL (normal
range: < 5.0 ng/mL); normal carcinoembryonic antigen
2.83 ng/mL (normal range: < 5.0 ng/mL); abnormal serum
carbohydrate antigen 19-9 53.4 ng/mL (normal range:
0e37 ng/mL); and abnormal anti-squamous cell carcinoma
antigen 8.1 ng/mL (normal range: 0e2.1 ng/mL). Hepatitis
B surface antigen and hepatitis C virus antibody were both
negative. Blood EBV viral load was 82,801 copies/mL. Stoolesion occupying both lobes of the liver showed hypointensity on
B), and diffusion-weighted imaging (C). During dynamic study,
Figure 2 Hematoxylin and eosin staining of this liver tissue
revealed some pleomorphic tumor cells with occasional mul-
tinucleation (arrow; magnification 400).
Figure 4 In situ hybridization of tumor cells revealed nuclear
staining for EpsteineBarr virus early RNAs (arrow; magnifica-
tion 400).
Nasopharyngeal carcinoma with liver metastasis 71examination was normal. Abdominal plain film radiography
disclosed no remarkable findings, except a nonspecific
bowel gas pattern. Abdominal ultrasonography showed a
lobulated cystic lesion about 20 cm  16.5 cm  17 cm,
with mixed solid and cystic parts occupying occupying both
lobes of the liver. Abdominal magnetic resonance imaging
(MRI) showed a well-defined, lobulated cystic lesion with
poor contrast enhancement occupying both lobes of the
liver (Fig. 1). Nasopharyngoscopy performed by an ear,
nose, and throat specialist demonstrated no local mass le-
sions. Only mild protruding on the central part of naso-
pharynx was noted and biopsies were taken.
Esophagogastroduodenoscopy was performed to exclude
malignancy of upper gastrointestinal origin. Only esopha-
geal Candida colonization was found. For the definite
diagnosis, biopsies from this cystic lesion were performed
with the assistance of ultrasonography.
Pathological examinations of nasopharyngeal biopsies
showed only squamous hyperplasia with parakeratosis and
focal moderate dysplasia without evidence of NPC recur-
rence. Histological examinations of the liver cystic neoplasm
revealed some pleomorphic cells with a few spindle nuclei
and frequent mitoses arranged in a solid nested pattern
infiltrating the stroma (Fig. 2). Poorly differentiated squa-
mous cell carcinoma with focal sarcomatoid differentiationFigure 3 p40 immunohistochemical stain revealed tumor cells
of squamous epithelial origin (arrow; magnification 400).was implied, based on the P40 immunohistochemical stain
(Fig. 3). In addition to p40 immunohistochemical stain, in
situ hybridization for EBERs was also positive (Fig. 4). Ac-
cording to the past history and pathological evidence, met-
astatic NPC was confirmed. The patient underwent oral
anticancer treatment with tegafur/uracil 100 mg/224 mg,
two tablets twice daily, and was followed up at a regional
medical institution. The size of the liver cystic metastatic
lesion decreased after 3 months anti-cancer treatment.Discussion
Liver cystic tumors may be solitary or multiple and can vary
from benign to malignant and represent a diagnostic chal-
lenge in clinical practice. Cystic metastasis is the most
important diagnosis to be excluded when multiple cystic
lesions are observed in the liver. The cystic nature of some
metastases is hypothesized to be secondary to rapid growth
than the hepatic arterial supply of tumors, leading to central
necrosis [4]. Hepatic metastases may originate from rapidly
growing malignancy such as hypervascular tumors (sarcoma,
melanoma, carcinoid, neuroendocrine tumors, and some
lung and breast tumors) or from mucinous colonic or ovarian
adenocarcinomas [5]. Colonic adenocarcinomas account for
w50% of all multiple cystic liver metastases in adults [6].
Radiology may demonstrate the degree of liver involvement,
multiplicity, border definitions, vessel displacement, and
dynamic enhancement patterns [5]. Several studies have
compared the diagnostic efficacy of MRI and computed to-
mography in patients with focal hepatic malignancies, and
have demonstrated that MRI has better contrast resolution
and can detect and characterize focal liver lesions with
greater accuracy than computed tomography [7,8]. This is
the reason why we chose abdominal MRI for further diag-
nostic assessment in the present case. However, it is difficult
to make an accurate diagnosis simply from imaging. A clin-
ical history of a known primary malignancy may help the
diagnosis of liver cystic metastases, which can be confirmed
by imaging-guided tissue biopsy and pathology.
NPC with liver metastasis usually presents with solitary
or multiple solid tumors. Liver cystic metastatic lesions
deriving from NPC have only been reported once [2].
72 K.-W. Chen et al.Specific marker such as EBERs can be a useful tool for
identification of the origin of metastatic NPC. EBV is asso-
ciated with undifferentiated NPC. EBERs are often used as a
marker to detect EBV-infected NPC cells [9]. Maohuai et al
[10] demonstrated that in situ hybridization of EBERs in
cytological smears had a role in the diagnosis of NPC, with a
sensitivity of 92% and specificity of 100%. Chao et al [11]
also demonstrated that EBERs can be used as a sensitive
marker to identify NPC cells at various metastatic sites by
in situ hybridization. That means that demonstration of
EBERs in lesions of undifferentiated histology may be a
useful diagnostic adjunct for NPC presenting as metastatic
cancer of unknown origin [11]. Ho et al [12] demonstrated
that all the primary lesions and the metastatic tumors of
NPC with undifferentiated histology contained EBERs in the
nuclei of cancer cells. EBERs can be detected in cells of the
distant, relapsed metastatic sites, even when the primary
tumor is cured. Therefore, EBERs can be useful to define
the nature of a newly developed tumor in patients with a
history of NPC. In our patient, EBERs were positive in the
histology of liver cystic metastases, which confirmed that
these metastases were from locally controlled NPC and
helped to establish the final diagnosis.
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